MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Retraction]

Abstract

Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175. We, the Editors and Publisher of Cancer Management and Research, have retracted the following article. Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors were cooperative but were unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were informed of this decision. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Keywords

• hepatic carcinoma
• mir-145
• toll-like receptor 4 (tlr4)
• 5- fluorouracil
• drug resistance